PURPOSE: The purpose of our study was to evaluate the efficacy of computed-tomography (CT)-guided transthoracic needle biopsy (TNB) and fine needle aspiration (FNA) in diagnosing pulmonary infectious diseases. PATIENTS AND METHODS: We retrospectively reviewed the medical records of patients treated at our institution between October 2006 and September 2009 and identified 161 patients who had undergone CT-guided TNB or FNA. We conducted CT-guided TNB or FNA for the patients if bronchoscopy failed to provide proper diagnosis or if their thoracic lesions were not appropriate targets for bronchoscopy. RESULTS: Twenty-three patients were diagnosed with pulmonary infectious diseases, of whom 17 were diagnosed by CT-guided TNB or FNA; sensitivity was therefore 73.9 % (17/23). The diagnostic rate for Aspergillus infection was especially high (75 %). CONCLUSION: CT-guided TNB and FNA proved to be effective as alternative methods if bronchoscopy failed to diagnose pulmonary infectious diseases, with acceptable complication rates.
PURPOSE: The purpose of our study was to evaluate the efficacy of computed-tomography (CT)-guided transthoracic needle biopsy (TNB) and fine needle aspiration (FNA) in diagnosing pulmonary infectious diseases. PATIENTS AND METHODS: We retrospectively reviewed the medical records of patients treated at our institution between October 2006 and September 2009 and identified 161 patients who had undergone CT-guided TNB or FNA. We conducted CT-guided TNB or FNA for the patients if bronchoscopy failed to provide proper diagnosis or if their thoracic lesions were not appropriate targets for bronchoscopy. RESULTS: Twenty-three patients were diagnosed with pulmonary infectious diseases, of whom 17 were diagnosed by CT-guided TNB or FNA; sensitivity was therefore 73.9 % (17/23). The diagnostic rate for Aspergillus infection was especially high (75 %). CONCLUSION: CT-guided TNB and FNA proved to be effective as alternative methods if bronchoscopy failed to diagnose pulmonary infectious diseases, with acceptable complication rates.
Authors: F Laspas; A Roussakis; R Efthimiadou; D Papaioannou; S Papadopoulos; J Andreou Journal: J Med Imaging Radiat Oncol Date: 2008-10 Impact factor: 1.735
Authors: Sanjay Gupta; Mark Sultenfuss; Jorge E Romaguera; Joe Ensor; Savitri Krishnamurthy; Michael J Wallace; Kamran Ahrar; David C Madoff; Ravi Murthy; Marshall E Hicks Journal: Hematol Oncol Date: 2010-06 Impact factor: 5.271
Authors: Kum Ju Chae; Hyunsook Hong; Soon Ho Yoon; Seokyung Hahn; Gong Yong Jin; Chang Min Park; Jin Mo Goo Journal: Sci Rep Date: 2019-08-27 Impact factor: 4.379